|
Phenotypic Information (metabolism pathway, cancer, disease, phenome) | |
Gene-Gene Network Information: Co-Expression Network, Interacting Genes & KEGG | |
Gene Summary for NUDT2 |
Basic gene info. | Gene symbol | NUDT2 |
Gene name | nudix (nucleoside diphosphate linked moiety X)-type motif 2 | |
Synonyms | APAH1 | |
Cytomap | UCSC genome browser: 9p13 | |
Genomic location | chr9 :34329503-34343711 | |
Type of gene | protein-coding | |
RefGenes | NM_001161.4, NM_001244390.1,NM_147172.2,NM_147173.2, | |
Ensembl id | ENSG00000164978 | |
Description | Ap4A hydrolase 1Ap4Aasebis(5'-nucleosyl)-tetraphosphatase (asymmetrical)bis(5'-nucleosyl)-tetraphosphatase [asymmetrical]diadenosine 5',5'''-P1,P4-tetraphosphate asymmetrical hydrolasediadenosine 5',5''-P1,P4-tetraphosphate pyrophosphohydrolasediade | |
Modification date | 20141207 | |
dbXrefs | MIM : 602852 | |
HGNC : HGNC | ||
Ensembl : ENSG00000164978 | ||
HPRD : 04168 | ||
Vega : OTTHUMG00000019817 | ||
Protein | UniProt: P50583 go to UniProt's Cross Reference DB Table | |
Expression | CleanEX: HS_NUDT2 | |
BioGPS: 318 | ||
Gene Expression Atlas: ENSG00000164978 | ||
The Human Protein Atlas: ENSG00000164978 | ||
Pathway | NCI Pathway Interaction Database: NUDT2 | |
KEGG: NUDT2 | ||
REACTOME: NUDT2 | ||
ConsensusPathDB | ||
Pathway Commons: NUDT2 | ||
Metabolism | MetaCyc: NUDT2 | |
HUMANCyc: NUDT2 | ||
Regulation | Ensembl's Regulation: ENSG00000164978 | |
miRBase: chr9 :34,329,503-34,343,711 | ||
TargetScan: NM_001161 | ||
cisRED: ENSG00000164978 | ||
Context | iHOP: NUDT2 | |
cancer metabolism search in PubMed: NUDT2 | ||
UCL Cancer Institute: NUDT2 | ||
Assigned class in ccmGDB | B - This gene belongs to cancer gene. |
Top |
Phenotypic Information for NUDT2(metabolism pathway, cancer, disease, phenome) |
Cancer Description | |
Cancer | CGAP: NUDT2 |
Familial Cancer Database: NUDT2 |
* This gene is included in those cancer gene databases. |
. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Oncogene 1 | Significant driver gene in |
cf) number; DB name 1 Oncogene; http://nar.oxfordjournals.org/content/35/suppl_1/D721.long, 2 Tumor Suppressor gene; https://bioinfo.uth.edu/TSGene/, 3 Cancer Gene Census; http://www.nature.com/nrc/journal/v4/n3/abs/nrc1299.html, 4 CancerGenes; http://nar.oxfordjournals.org/content/35/suppl_1/D721.long, 5 Network of Cancer Gene; http://ncg.kcl.ac.uk/index.php, 1Therapeutic Vulnerabilities in Cancer; http://cbio.mskcc.org/cancergenomics/statius/ |
Metabolic Pathway Description | |
KEGG_PURINE_METABOLISM KEGG_PYRIMIDINE_METABOLISM |
Others | |
OMIM | 602852; gene. |
Orphanet | |
Disease | KEGG Disease: NUDT2 |
MedGen: NUDT2 (Human Medical Genetics with Condition) | |
ClinVar: NUDT2 | |
Phenotype | MGI: NUDT2 (International Mouse Phenotyping Consortium) |
PhenomicDB: NUDT2 |
Mutations for NUDT2 |
* Under tables are showing count per each tissue to give us broad intuition about tissue specific mutation patterns.You can go to the detailed page for each mutation database's web site. |
Structural Variants in COSMIC: go to COSMIC mutation histogram |
- Statistics for Tissue and Mutation type | Top |
- For Inter-chromosomal Variations |
There's no inter-chromosomal structural variation. |
- For Intra-chromosomal Variations |
* Intra-chromosomal variantions includes 'intrachromosomal amplicon to amplicon', 'intrachromosomal amplicon to non-amplified dna', 'intrachromosomal deletion', 'intrachromosomal fold-back inversion', 'intrachromosomal inversion', 'intrachromosomal tandem duplication', 'Intrachromosomal unknown type', 'intrachromosomal with inverted orientation', 'intrachromosomal with non-inverted orientation'. |
Sample | Symbol_a | Chr_a | Start_a | End_a | Symbol_b | Chr_b | Start_b | End_b |
breast | NUDT2 | chr9 | 34338965 | 34338965 | NUDT2 | chr9 | 34340963 | 34340963 |
cf) Tissue number; Tissue name (1;Breast, 2;Central_nervous_system, 3;Haematopoietic_and_lymphoid_tissue, 4;Large_intestine, 5;Liver, 6;Lung, 7;Ovary, 8;Pancreas, 9;Prostate, 10;Skin, 11;Soft_tissue, 12;Upper_aerodigestive_tract) |
Related fusion transcripts : go to Chitars2.0 |
* From mRNA Sanger sequences, Chitars2.0 arranged chimeric transcripts. This table shows NUDT2 related fusion information. |
ID | Head Gene | Tail Gene | Accession | Gene_a | qStart_a | qEnd_a | Chromosome_a | tStart_a | tEnd_a | Gene_a | qStart_a | qEnd_a | Chromosome_a | tStart_a | tEnd_a |
N45093 | NUDT2 | 1 | 401 | 9 | 34343294 | 34343695 | NUDT2 | 397 | 486 | 9 | 34343186 | 34343275 |
Other DBs for Structural Variants |
Top |
Copy Number Variations in COSMIC: go to COSMIC mutation CNV/Expr |
Mutation type/ Tissue ID | brca | cns | cerv | endome | haematopo | kidn | Lintest | liver | lung | ns | ovary | pancre | prost | skin | stoma | thyro | urina | |||
Total # sample | 1 |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   | |||
GAIN (# sample) |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   | |||
LOSS (# sample) | 1 |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |
cf) Tissue ID; Tissue type (1; Breast, 2; Central_nervous_system, 3; Cervix, 4; Endometrium, 5; Haematopoietic_and_lymphoid_tissue, 6; Kidney, 7; Large_intestine, 8; Liver, 9; Lung, 10; NS, 11; Ovary, 12; Pancreas, 13; Prostate, 14; Skin, 15; Stomach, 16; Thyroid, 17; Urinary_tract) |
Top |
SNV Counts per Each Loci in COSMIC data: go to COSMIC point mutation |
|
Top |
Somatic Mutation Counts per Tissue in COSMIC data |
Stat. for Non-Synonymous SNVs (# total SNVs=7) | (# total SNVs=1) |
(# total SNVs=0) | (# total SNVs=0) |
Top |
Top 10 SNVs Having the Most Samples in COSMIC data |
* When you move the cursor on each content, you can see more deailed mutation information on the Tooltip. Those are primary_site,primary_histology,mutation(aa),pubmedID. |
GRCh37 position | Mutation(aa) | Unique sampleID count |
chr9:34343338-34343338 | p.R115H | 2 |
chr9:34343290-34343290 | p.K99R | 1 |
chr9:34343315-34343315 | p.L107L | 1 |
chr9:34343327-34343327 | p.H111H | 1 |
chr9:34339041-34339041 | p.A2T | 1 |
chr9:34343328-34343328 | p.Q112E | 1 |
chr9:34339065-34339065 | p.I10L | 1 |
chr9:34339067-34339067 | p.I10M | 1 |
chr9:34343383-34343383 | p.E130A | 1 |
chr9:34339072-34339072 | p.R12Q | 1 |
Top |
SNV Counts per Each Loci in TCGA data |
|
Point Mutation/ Tissue ID | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19 | 20 |
# sample |   | 1 |   | 1 | 1 |   | 1 |   |   |   |   | 3 | 1 |   |   |   |   | 3 |   | 1 |
# mutation |   | 1 |   | 1 | 1 |   | 1 |   |   |   |   | 3 | 1 |   |   |   |   | 3 |   | 1 |
nonsynonymous SNV |   | 1 |   |   | 1 |   | 1 |   |   |   |   | 3 | 1 |   |   |   |   | 3 |   | 1 |
synonymous SNV |   |   |   | 1 |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |
cf) Tissue ID; Tissue type (1; BLCA[Bladder Urothelial Carcinoma], 2; BRCA[Breast invasive carcinoma], 3; CESC[Cervical squamous cell carcinoma and endocervical adenocarcinoma], 4; COAD[Colon adenocarcinoma], 5; GBM[Glioblastoma multiforme], 6; Glioma Low Grade, 7; HNSC[Head and Neck squamous cell carcinoma], 8; KICH[Kidney Chromophobe], 9; KIRC[Kidney renal clear cell carcinoma], 10; KIRP[Kidney renal papillary cell carcinoma], 11; LAML[Acute Myeloid Leukemia], 12; LUAD[Lung adenocarcinoma], 13; LUSC[Lung squamous cell carcinoma], 14; OV[Ovarian serous cystadenocarcinoma ], 15; PAAD[Pancreatic adenocarcinoma], 16; PRAD[Prostate adenocarcinoma], 17; SKCM[Skin Cutaneous Melanoma], 18:STAD[Stomach adenocarcinoma], 19:THCA[Thyroid carcinoma], 20:UCEC[Uterine Corpus Endometrial Carcinoma]) |
Top |
Top 10 SNVs Having the Most Samples in TCGA data |
* We represented just top 10 SNVs. When you move the cursor on each content, you can see more deailed mutation information on the Tooltip. Those are primary_site, primary_histology, mutation(aa), pubmedID. |
Genomic Position | Mutation(aa) | Unique sampleID count |
chr9:34339067 | p.I10M,NUDT2 | 2 |
chr9:34343315 | p.A2T,NUDT2 | 1 |
chr9:34343328 | p.I10L,NUDT2 | 1 |
chr9:34343338 | p.R12Q,NUDT2 | 1 |
chr9:34339041 | p.R57M,NUDT2 | 1 |
chr9:34339065 | p.A63V,NUDT2 | 1 |
chr9:34339072 | p.K99R,NUDT2 | 1 |
chr9:34343164 | p.I105F,NUDT2 | 1 |
chr9:34343182 | p.L107L,NUDT2 | 1 |
chr9:34343290 | p.Q112E,NUDT2 | 1 |
Other DBs for Point Mutations |
Copy Number for NUDT2 in TCGA |
* Copy number data were extracted from TCGA using R package TCGA-Assembler. The URLs of all public data files on TCGA DCC data server were gathered on Jan-05-2015. Function ProcessCNAData in TCGA-Assembler package was used to obtain gene-level copy number value which is calculated as the average copy number of the genomic region of a gene. |
cf) Tissue ID[Tissue type]: BLCA[Bladder Urothelial Carcinoma], BRCA[Breast invasive carcinoma], CESC[Cervical squamous cell carcinoma and endocervical adenocarcinoma], COAD[Colon adenocarcinoma], GBM[Glioblastoma multiforme], Glioma Low Grade, HNSC[Head and Neck squamous cell carcinoma], KICH[Kidney Chromophobe], KIRC[Kidney renal clear cell carcinoma], KIRP[Kidney renal papillary cell carcinoma], LAML[Acute Myeloid Leukemia], LUAD[Lung adenocarcinoma], LUSC[Lung squamous cell carcinoma], OV[Ovarian serous cystadenocarcinoma ], PAAD[Pancreatic adenocarcinoma], PRAD[Prostate adenocarcinoma], SKCM[Skin Cutaneous Melanoma], STAD[Stomach adenocarcinoma], THCA[Thyroid carcinoma], UCEC[Uterine Corpus Endometrial Carcinoma] |
Top |
Gene Expression for NUDT2 |
Gene Expression in Cancer Cell-lines (CCLE) |
* CCLE gene expression data were extracted from CCLE_Expression_Entrez_2012-10-18.res: Gene-centric RMA-normalized mRNA expression data. |
Differential Gene Expression in Primary Tumors (TCGA) |
* Normalized gene expression data of RNASeqV2 was extracted from TCGA using R package TCGA-Assembler. The URLs of all public data files on TCGA DCC data server were gathered at Jan-05-2015. Only eight cancer types have enough normal control samples for differential expression analysis. (t test, adjusted p<0.05 (using Benjamini-Hochberg FDR)) |
Top |
CNV vs Gene Expression Plot |
* This plots show the correlation between CNV and gene expression. |
Top |
Gene-Gene Network Information |
Co-Expressed gene's network Plot |
* Co-Expression network figures were drawn using R package igraph. Only the top 20 genes with the highest correlations were shown. Red circle: input gene, orange circle: cell metabolism gene, sky circle: other gene |
APTX,BLOC1S1,IFT43,LAMTOR4,RPP25L,CCDC12,CHCHD5, COQ4,DCTN3,EDF1,MZT2B,FIS1,GRHPR,HINT2, NAA38,MRPL54,NDUFB6,NUDT2,PHPT1,LAMTOR2,TMEM219 | ARL16,ARL6IP4,GPANK1,BUD31,LAMTOR4,SWI5,CBY1, CHMP2A,FUZ,MEA1,MGMT,NT5C,NUDT2,PIN4, PPCDC,R3HCC1,NELFE,SDHAF1,SURF2,TFPT,ZNF688 |
ACN9,BNIP1,PTRHD1,RPP25L,CHCHD1,DCTN3,GRHPR, GSTO1,MCEE,MRPL43,MRPL54,NDUFA2,NDUFA8,NDUFB6, NUDCD2,NUDT2,RBX1,RPL35,RPS14,STOML2,TRUB2 | KANSL2,C12orf57,IFT43,C17orf75,SMIM11,FAU,FIS1, HMGN4,HSCB,NFU1,NUDT2,OST4,PFDN5,RNF41, RPL35A,S100A13,TATDN3,TINF2,EMC4,TRNAU1AP,ZNF32 |
Co-Expressed gene's Protein-protein interaction Network Plot |
* Co-Expression network figures were drawn using R package igraph. Only the top 20 genes with the highest correlations were shown. Red circle: input gene, orange circle: cell metabolism gene, sky circle: other gene |
Top |
Interacting Genes (from Pathway Commons) |
Top |
Pharmacological Information for NUDT2 |
There's no related Drug. |
Top |
Cross referenced IDs for NUDT2 |
* We obtained these cross-references from Uniprot database. It covers 150 different DBs, 18 categories. http://www.uniprot.org/help/cross_references_section |
Copyright © 2016-Present - The Univsersity of Texas Health Science Center at Houston @ |